Catalyst Wire Dossier Catalyst Wire Dossier

rMenB + MenACWY combination vaccine

recombinant MenB plus MenACWY meningococcal vaccine · Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rMenB + MenACWY combination vaccine, covering 2014-11-19 to 2014-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines [Phase 2]

See pricing